Lipella Pharmaceuticals
PITTSBURGH, Pennsylvania, United States · Biopharma, Biotechnology, Healthcare
Lipella is a biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well as improved surveillance and imaging of patients with a history of transitional cell carcinoma. We are also applying our proprietary drug delivery to the oral mucosa for the treatmen
Key facts
- Headquarters
- PITTSBURGH, Pennsylvania, United States
- Employees
- 5
- Industries
- Biopharma, Biotechnology, Healthcare
- Status
- Public (LIPO)
- Website
- lipella.com
- Company page
Recent activity at Lipella Pharmaceuticals
- : SEC 8-K (5.02): On February 3, 2026, Lori A. Birder resigned from her position on the Board of Directors of Lipella Pharmaceuticals Inc., effective immediately. Her resignation was confirmed not to be related to any disagreements concerning the Company's operations, policies, or practices. This change may signal a shift in governance and could have implications for the strategic direction of the company. The timing of her departure immediately before the reporting date highlights the absence of any planned transition or succession announcement.
- : LIPELLA PHARMACEUTICALS
- : LIPELLA PHARMACEUTICALS
- : LIPELLA PHARMACEUTICALS
- : Lipella Pharmaceuticals Closes $1.28 Million Direct Offering of Common Stock Under Nasdaq Rules
- : LIPELLA PHARMACEUTICALS
- : LIPELLA PHARMACEUTICALS INC
- : LIPELLA PHARMACEUTICALS INC
- : LIPELLA PHARMACEUTICALS INC
Lipella Pharmaceuticals funding history
| Date | Round | Amount |
|---|---|---|
| Apr 2025 | Seed | $9K |
| Jan 2025 | Seed | $2.6M |
| Aug 2024 | Venture | $120K |
| Nov 2023 | Seed | $3.1M |
| May 2021 | Seed | $3.1M |
Leadership
- Jonathan Kaufman, Executive Officer, Director
- Michael Chancellor, Director
- JONATHAN KAUFMAN, Executive Officer, Director
- MICHAEL CHANCELLOR, Director
- THOMAS JR., Director
- DAVID BATTLEMAN, Director
- JONATHAN KAUFMAN, Executive Officer, Director
- MICHAEL CHANCELLOR, Director
- THOMAS JR., Director
- DAVID BATTLEMAN, Director
Verified email and direct lines for Lipella Pharmaceuticals’s decision-makers are on Fundz. See plans
Employee benefit plans
Lipella Pharmaceuticals files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Lipella Pharmaceuticals in the news
- Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market - GlobeNewswire (Jun 20, 2025)
- Lipella Pharmaceuticals files for bankruptcy protection four years after going public - WPXI (Apr 02, 2026)
- Lipella Pharmaceuticals files for bankruptcy protection four years after going public - The Business Journals (Mar 31, 2026)
- Lipella Pharmaceuticals Inc. (LIPO) Stock Price, News, Quote & History - Yahoo! Finance Canada (Jan 09, 2023)
- FDA Clears Investigational New Drug Application for Lipella’s Oral Lichen Planus Treatment - Pharmaceutical Executive (Oct 20, 2023)
- Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement with Cook MyoSite - BioSpace (Apr 17, 2023)
- Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research - GlobeNewswire (Aug 22, 2024)
- Money Moves: Ansys grows via acquisition and Lipella Pharmaceuticals goes public - Technical.ly (Jan 03, 2023)
Companies similar to Lipella Pharmaceuticals
- Savara Inc · Biopharma, Biotechnology, Healthcare, Health Care, Medical, Pharmaceutical, Therapeutics
- Aquestive Therapeutics, Inc. · Biopharma, Biotechnology, Healthcare, Health Care, Medical, Pharmaceutical, Therapeutics
- Os Therapies · Biopharma, Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Galmed Pharmaceuticals Ltd · Biopharma, Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- AbbVie Inc. · Biopharma, Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
About Lipella Pharmaceuticals: questions and answers
What does Lipella Pharmaceuticals do?
Lipella is a biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well as improved surveillance and imaging of patients with a history of transitional cell carcinoma. We are also applying our proprietary drug delivery to the oral mucosa for the treatmen
Where is Lipella Pharmaceuticals headquartered?
Lipella Pharmaceuticals is headquartered in PITTSBURGH, Pennsylvania, United States.
How many employees does Lipella Pharmaceuticals have?
Lipella Pharmaceuticals has about 5 employees.
Has Lipella Pharmaceuticals raised funding?
Yes. Fundz has recorded 5 funding events for Lipella Pharmaceuticals. The most recent, Seed of $9K, was in Apr 2025.
What is the latest news on Lipella Pharmaceuticals?
On Feb 03, 2026, SEC 8-K (5.02): On February 3, 2026, Lori A. Birder resigned from her position on the Board of Directors of Lipella Pharmaceuticals Inc., effective immediately. Her resignation was confirmed not to be related to any disagreements concerning the Company's operations, policies, or practices. This chan
Is Lipella Pharmaceuticals a public company?
Yes. Lipella Pharmaceuticals is publicly traded under the ticker LIPO.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy